Comprehensive Metabolic Profiling of MYC-Amplified Medulloblastoma Tumors Reveals Key Dependencies on Amino Acid, Tricarboxylic Acid and Hexosamine Pathways.
Level 5 - mechanism / opinion, no new human data
Preclinical in vitro and animal xenograft laboratory study.
PubMed 35267619 · doi:10.3390/cancers14051311
What was done
Researchers conducted metabolomic profiling of human MYC-amplified medulloblastoma cells across three experimental conditions: in vitro cell culture, subcutaneous flank xenografts, and orthotopic cerebellar xenografts in mice, comparing metabolic phenotypes to each other and to normal brain tissue using principal component analysis and pathway tracing.
What was found
The abstract reports pathway directions without specific numerical values: - Metabolic profiles of in vivo brain and flank tumors clustered closely together and separated distinctly from normal brain and in vitro cell cultures. - Orthotopic tumors showed upregulation of the TCA cycle and increased synthesis of nucleotides, hexosamines, amino acids, and glutathione compared to normal brain. - Glucose uptake and utilization were significantly higher in orthotopic xenografts than in flank xenografts and cultured cells. - In orthotopic tumors, glucose was the main carbon source for de novo synthesis of glutamate, glutamine, and glutathione through the TCA cycle. - Glutathione was the most abundant upregulated metabolite in orthotopic tumors, synthesized from glutamine via the glutaminase II pathway and glutamine transaminase K (GTK) in vivo.
Why it matters
The findings demonstrate that in vitro cell culture misses critical in vivo metabolic dependencies of MYC-amplified medulloblastoma, identifying the TCA cycle and GTK-mediated glutathione synthesis as potential target pathways.
Limits
The abstract reports no quantitative values, effect sizes, variance estimates, or sample sizes (number of cell lines or animals). Findings are derived from animal xenograft models rather than direct patient tissue measurements, and therapeutic efficacy of inhibiting these pathways was not evaluated.
Cited by
- supports Pediatric brain tumors are metabolically dependent on both glucose and glutamine for growth.